§ 369.3. Warnings required on drugs exempted from prescription-dispensing requirements of section 503(b)(1)(C).
103 words·~1 min read·
/us/cfr/t21/s§ 369.3·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Drugs exempted from prescription-dispensing requirements under section 503(b)(1)(C) of the act are subject to the labeling requirements prescribed in § 310.201(a) of this chapter. Although, for convenience, warning and caution statements for a number of the drugs named in § 310.201 of this chapter (cross-referenced in the text of this part) are included in subpart B of this part, the inclusion of such drugs in §§ 369.20 or 369.21 in no way affects the requirements for compliance with § 310.201(a) of this chapter, or the provisions of an effective application pursuant to section 505(b) of the act. [85 FR 72907, Nov. 16, 2020]
Connections1 cite this
Cited by 1 section
register
Citation graph
cites case law
§ 369.3
Warnings required on drugs exempted from prescription-dispensing requirements of section 503(b)(1)(C).
Fed. Reg.×1
Cites 0Cited by 1 across 1 source